Tradestie Institutional Equity Comparison Engine

BMRA vs SGHT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGHT Overall Edge

SGHT Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus SGHT at N/M Forward P/E and -20.2% operating margin (+25.2% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BMRA N/M vs SGHT N/M Fwd P/E
Growth & Margin Winner SGHT
Op Margin -125.2% vs -20.2% ยท YoY -8.3% vs +25.2%
Momentum & Technical Winner SGHT
1Y -45.6% vs +50.2% ยท 52W Pos 5% vs 88%
Options & Structure Winner SGHT
UNCLASSIFIED (N/A IV) vs BREAKOUT (8th %ile IV)
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap $6.0M
1M Return -26.49%
1Y Return -45.6%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0
SGHT NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.59
-2.22% 1D
Market Cap $610.8M
1M Return +27.9%
1Y Return +50.21%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 50.0 Fund 32.0 Flow 57.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMRA -45.6% SGHT +50.21% Spread: +95.81 pp (SGHT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMRA Revenue SGHT Revenue BMRA Op. Margin SGHT Op. Margin Margin Edge
FY2019 $10M N/A -46.4% N/A BMRA
FY2020 $10M $30M -41.0% -116.5% BMRA
FY2021 $10M $50M -104.2% -105.2% BMRA
FY2022 $20M $70M -24.0% -117.7% BMRA
FY2023 $10M $80M -135.3% -70.7% SGHT
FY2024 $10M $80M -117.6% -63.3% SGHT
FY2025 $10M $80M -96.7% -48.0% SGHT
FY2026 $0M N/A -119.5% N/A BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMRA (1) vs SGHT (7)
Institutional Metric BMRA SGHT Criterion Row Winner
Market Capitalization Scale $6.0M $610.8M Larger Scale SGHT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -8.3% +25.2% Higher Growth SGHT
Operating Margin (TTM) Profitability -125.2% -20.2% Higher Margin SGHT
Net Profit Margin Profitability -115.5% -32.1% Higher Margin SGHT
Return on Equity (ROE) Capital Efficiency -113.8% -50.1% Higher ROE SGHT
52-Week Range Position Momentum 5% ($1โ€“$3) 88% ($3โ€“$12) Stronger Trend SGHT
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 62% Vol 1.06ฮฒ ยท 46% Vol Lower Realized Risk SGHT
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 35.1 / 100 (SELL) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMRA vs SGHT Buy Guide
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGHT BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live SGHT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMRA nor SGHT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.